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Background: Intraocular pressure (IOP) may vary according to the change of ocular conditions. In this study, we
want to assess the effect and mechanism of pupil dilation on IOP in normal subjects.
Methods: We prospectively evaluated 32 eyes of 32 patients (age; 61.7 ± 8.2 years) with normal open angles under
diurnal IOP. IOP was measured every two hours from 9 AM to 11 PM for one day to establish baseline values and
was measured again for one day to assess the differences after dilation. To induce dilation, we administered 2.5%
phenylephrine and 1% tropicamide every 5 minutes from 8:30 AM to 8:45 AM and for every two hours from 11 AM
to 9 PM to keep the pupil dilated. Diurnal IOP, biometry, Visante OCT, and laser flare photometry were measured
before and after dilation.
Results: We observed a significant increase in IOP after dilation, 1.85 ± 2.01 mmHg (p= 0.002). IOP elevation
remained significant until about four hours after dilation. Thereafter, IOP decreased slowly and eventually reached
pre-dilation level (p> 0.05). Flare values decreased, and the anterior chamber angle became wider after mydriasis.
Conclusions: Dilation of the pupil significantly and incidentally elevated IOP in normal subjects. Further related
studies are warranted to characterize the mechanism of the increased IOP after dilation.
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Like many biological parameters, IOP is a dynamic par-
ameter and varies throughout the course of 24 hours,
possibly following circadian rhythms. The mean range of
diurnal IOP variation is approximately 2 to 6 mmHg in
the normal population and 5 to 18 mmHg in glaucoma
patients [1,2]. IOP variation can be affected by many fac-
tors such as medication, posture, exercise, blinking, eye
movements, and Valsalva manoeuvres [3,4]. As such,
clinicians are advised to conduct multiple measurements
over 24 hours to assess the IOP profiles of at-risk
patients.
Mydriatics are regularly used to dilate pupils in
patients presenting to ophthalmology clinics for assess-
ment and follow-up of a wide variety of ophthalmic con-
ditions. An increase in IOP has been observed after* Correspondence: kihopark@snu.ac.kr
2Department of Ophthalmology, Seoul National University College of
Medicine, Seoul National University Hospital, Seoul, Korea
Full list of author information is available at the end of the article
© 2012 Kim et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordilation with topical application of both parasympatholy-
tic and sympathomimetic mydriatics [5-7]. However, the
mechanism of IOP elevation after dilation is not clear.
This prospective study was performed to investigate
the effect and mechanism of dilation on IOP in normal
subjects.Methods
This study adhered to the tenets of the Declaration of
Helsinki and was approved by the institutional review
board of Kangbuk Samsung Hospital in Seoul, Korea.
We examined 32 eyes of 32 patients (17 women and 15
men, age; 61.7 ± 8.2 years) who provided informed con-
sent. All subjects were patients scheduled for a bilateral
cataract operation who underwent a full ophthalmic
examination including visual acuity, Goldmann applana-
tion tonometry, gonioscopy, slit lamp evaluation, fundus
biomicroscopy, auto refractometry (RK-F1, Canon,
Japan), and pachymetry (4000APW, SonomedW, USA).
All eyes presented as normal (except cataract) with an. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The variation of intraocular pressure (IOP) before






9 12.35 ± 3.06 12.54 ± 2.82 0.898
11 12.25 ± 3.12 14.33 ± 3.65 0.001*
13 11.49 ± 2.68 13.42 ± 3.30 <0.001*
16 11.57 ± 2.95 12.29 ± 2.58 0.051
17 11.70 ± 2.83 11.85 ± 2.30 0.604
19 11.42 ± 2.96 11.80 ± 2.82 0.372
21 11.39 ± 2.97 11.39 ± 2.46 0.799
23 11.32 ± 2.76 11.32 ± 2.58 0.944
* : p-value < 0.05.
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clusion criteria included the following: high IOP (>20
mmHg) on the visit before dilation; preoperative ocular
medication that could influence IOP level; pre-existing
ocular pathology such as glaucoma, uveitis, or high my-
opia; and previous ocular surgery.
IOP was measured in both eyes of each patient by
experienced personnel using a Goldmann applanation
tonometer every two hours from 9 AM to 11 PM to es-
tablish baseline values. On another day (1 ~ 3 months
after the baseline test), we induced mydriasis by admin-
istering one drop of Mydrin-P (fixed combination of
2.5% phenylephrine and 1% tropicamide, Santen Phar-
maceuticals, Osaka, Japan) in the conjunctival sac every
5 minutes from 8:30 AM to 8:45 AM and every two
hours from 11 AM to 9 PM to maintain a dilated state.
IOP was measured every two hours from 9 AM to
11 PM.
The following variables were assessed before and after
dilation: diurnal IOP, anterior segment examination,
axial length (AL), anterior chamber depth (ACD), central
corneal thickness (CCT), anterior chamber flare with
laser flare photometer (FM-500, Kowa, Tokyo, Japan),
and anterior chamber angle with Visante OCT (Carl
Zeiss Meditec, Dubin, CA, USA). AL and ACD were
measured with an IOL Master (Carl Zeiss Meditec,
Dubin, CA, USA). CCT was measured with a hand-held
ultrasonic pachymeter, and the average of three readings
was recorded.
The Visante OCT was used to perform anterior cham-
ber angle width measurements every two hours before
mydriasis and after instillation of mydriatics from 9 AM
to 9 PM. The average of three consecutive readings of
the mean angle value at 3 and 9 o’clock was included in
analysis. Laser flare photometry was performed once be-
fore mydriasis and every two hours after instillation of
mydriatics, from 9 AM to 5 PM. The laser flare photom-
eter quantifies anterior chamber protein (flare) and par-
ticles (cells) by measuring light scattering of a helium-
neon laser beam projected into the anterior chamber [8].
A single experienced investigator examined each subject
five times in series and recorded the mean value of the
five measurements. All examinations were performed in
a hospital setting. To reduce bias, a different measuring
technician, data collector, and statistical analyst partici-
pated in a masked fashion. The data were analyzed using
PASW statistics 17.0 (SPSS, Inc., Chicago, IL, USA), and
differences in values were assessed by paired t-test. A p-
value of less than 0.05 was considered statistically
significant.
Results
The mean pre-dilation IOP was 11.48 ± 2.85 mmHg. The
mean post-dilation IOP was 12.36 ± 2.58 mmHg. Thischange was statistically significant (p=0.005). The max-
imum IOP also significantly increased from a mean pre-
dilation level of 13.10 mmHg±2.91 to a post-dilation level
of 14.96±3.25 mmHg (p<0.001). However, there was no
significant difference between the minimum IOP before
(10.50 ± 2.74 mmHg) and after (10.50 ± 2.35 mmHg)
dilation (p = 0.978).
Regarding diurnal IOP variation, the mean pre-dilation
value was 2.60 ± 1.14 mmHg, and the mean post-dilation
value was 4.45 ± 2.01 mmHg. The difference in the mean
change of diurnal IOP variation was 1.85 ± 2.01 mmHg,
and this change was statistically significant (p= 0.002).
Diurnal IOP was elevated in 22 eyes (68.9%), decreased
in two, and unchanged in eight. We noted a non-
significant IOP increase at 9 AM, 30 minutes after dila-
tion. IOP was significantly increased at 11 AM and
1 PM (Table 1). Maximum IOP levels were reached at
11 AM, and after 3 PM, the IOP did not significantly dif-
fer (p > 0.05) from pre-dilation levels.
The flare value decreased after dilation and remained
constant (Figure 1). The width of the anterior chamber
angle increased significantly after dilation, and this state
was maintained while the pupil was dilated (p < 0.001)
(Figure 2). After dilation, we noted significantly
increased ACD values (3.20 ± 0.45 mm), as compared
with initial values (3.09 ± 0.48 mm) (p < 0.001). Mean
pupil diameter increased from 2.975 ± 0.498 mm to
6.725 ± 0.717 mm 2 hours after dilation and
6.793 ± 0.616 mm after 8 hours, but these changes were
not statistically significant (p > 0.05). There was no sig-
nificant variation of pupil size in either time interval
(p > 0.05).
IOP measurements after dilation were not related to
the mean pre-dilation IOP, AL, or diurnal IOP value
according to the results of multivariate analysis (range of
p-values: 0.232-0.966). Changes in the mean CCT and
axial length measurements before and after dilation were
not statistically significant.
Figure 1 Laser flare photometry values. Flare values decreased significantly after dilation and remained low. The arrows indicate the time
mydriatics were given. Intraocular pressure (IOP) at 9A.M. was measured before the mydriatics were instilled. To maintain pupil dilation, mydriatics
were instilled every 2 hours until 9 PM, just after IOP measurement.
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sustained increases in IOP. Only one patient experienced
a rise in IOP to a level greater than 21 mmHg after
dilation. The patient’s pressure dropped after an add-
itional two hours with no medical intervention. This
patient exhibited the highest pre-dilation IOP level of
all of our patients but did not have any other distinctive
findings.
Discussion
Tropicamide is an anticholinergic drug, and phenyleph-
rine is an alpha-1-adrenergic agent. These agents are
commonly used together to achieve mydriasis for fundus
examination [9-11]. It has previously been recognized
that pharmacologic mydriasis can cause an elevation in
IOP. According to one study, 1-2% of healthy persons
display a pressure elevation of 6 mmHg or more after
treatment with 1% cyclopentolate [5]. Harris and Galin
showed that 33% of miotic-treated patients with openFigure 2 Anterior chamber angle widths measured by Visante OCT. Aangle glaucoma respond to cycloplegics with a pressure
elevation [12]. Blake et al. found that significant pressure
elevation occurred in 32% of open angle glaucoma
patients following dilation with 2.5% phenylephrine and
1% tropicamide [13].
The mechanism responsible for IOP elevation after
dilation is unclear. Mydriatic agents can cause increases
in IOP that may be related to decreasing aqueous out-
flow resulting from decreased traction on the trabecular
meshwork due to ciliary muscle paralysis [14,15]. Under
the previously mentioned conditions, we can presume, if
the dilated state is maintained, increased IOP may be
preserved. The results of our study suggest a different
explanation. IOP was found to be significantly increased
at four hours and six hours after pupil dilation during
preserved pharmacologic mydriasis and slowly decreased
after that time. After dilation, the ACD deepened, the
anterior chamber angles widened, and the anterior
chamber flare decreased. Harris showed that a narrownterior chamber angles increased significantly after dilation.
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acute IOP elevation, but IOP elevation has been found
to occur in eyes that do not have narrow angles [16].
Valle reported that the key characteristic separating
responders to cyclopentolate from non-responders was
a difference in the inflow rate, [17] whereas the outflow
rate through the trabecular meshwork decreased with
cyclopentolate in all patients studied. The only statisti-
cally significant difference between the two groups was
that the inflow decreased in non-responders but increased
slightly in responders. In our study, the mean IOP
values decreased in two patients after dilation. Tem-
porary imbalance of aqueous flow may have an effect
on these patients. Also, dilation can cause a greater
anterior chamber depth and a wider contact region
between the trabecular meshwork and the aqueous.
There may be small amount of flare before the dila-
tion, and a small amount of flare may also occur due
to rubbing between iris and lens when the pupil begins
dilation. Thus, IOP may not increase after dilation. Fur-
ther evaluation with a larger population based study may
be needed.
Iris pigment liberation into the anterior chamber and
subsequent obstruction of the trabecular meshwork
has also been noted as a possible mechanism respon-
sible for the increase in IOP [18-20]. Kristensen showed
that 48% of eyes with open angle glaucoma showed a
rise in pressure of 8 mmHg or more after dilation,
and all elevations were associated with marked pig-
ment elevation [19]. Valle demonstrated IOP elevations of
up to 20 mmHg after dilation with 1% cyclopento-
late, all of which were accompanied by pigment liber-
ation [20].
In our study, we investigated aqueous flare and an-
terior chamber angles before and after mydriasis to
help determine the aetiology of increased IOP. We
demonstrated that anterior chamber angles widened
with dilation, which is possibly due to the posterior
pull of the dilated iris-lens diaphragm, leading to a
deep anterior chamber. The reduction in IOP after
3 pm may be explained by the widened anterior cham-
ber angle and improvement of the aqueous outflow fa-
cility. A decreased resistance to aqueous outflow may
be expected from deepening of the anterior chamber,
which creates a larger surface area between the tra-
becular meshwork and the aqueous humour [21]. How-
ever, IOP increased just after dilation, and we assessed
the variation in flare after dilation. Flare values
decreased after mydriasis (p < 0.01). The flare value
decreased just after dilation and remained decreased
while the pupil was dilated. It is possible that, just after
mydriasis, the flare may be increased by iris pigment
liberation or by protein, but crowding in the angle and
subsequent interruption through the outflow facility ofthe trabecular meshwork can explain the elevation of
intraocular pressure. Jewelewicz et al. reported similar
results in pigment dispersion syndrome cases [22]. The
maximal pigment liberation was reached 30 to 60 min-
utes after mydriasis, but peak IOP was reached about
90 minutes after mydriasis, when the anterior chamber
pigment was decreasing. Our cases have some differ-
ences. The flare decreased 30 minutes after instillation
of mydriatics. This might be because the subjects of
our study were normal, and normal subjects may have
a different response to dilation than pigment dispersion
syndrome patients. Another possibility was that we
used a combination drug. The included phenylephrine
could increase the clearance of flare/pigment. Racial
differences (only Koreans were included in our study)
should also be considered. Also, we took measure-
ments of fully dilated eyes, which can explain why we
did not observe more iris pigment liberation due to
lack of contact between the iris and lens. The my-
driasis effect may have increased vessel stability and
decreased flare.
Laser flare photometry is an objective, quantitative
method that enables accurate measurement with very
high sensitivity and reproducibility. Guillen-Monterrubio
et al. reported no significant differences in flare values
measured by flare photometer between right and left
eyes or between men and women [23].
There are some limitations in this study. Ocular para-
meters, such as corneal thickness and shape, [24,25] an-
terior chamber depth, [26] and axial length [25] are
known to undergo significant diurnal changes. We did
not control these factors. Angle and ACD are affected by
many external influences such as near vision or distance
vision, so it is difficult to measure the diurnal effect.
Also, corneal thickness may be changed due to epithelial
oedema by the repeated application of eye drops causing
the possible under measurement of IOP. This can affect
the decreased IOP of late diurnal measurements, but it
is difficult to calculate the cushion effect caused by epi-
thelial oedema. Further study is needed. IOP may change
as either diurnal variation or seasonal change. Qureshi
IA et al. reported that IOP tends to increase in the win-
ter [27]. The longest time interval of IOP measurement
among the patients was three months, which could pos-
sibly affect the variability.
Conclusions
According to the results of this study, pupil dilation
caused an elevation of IOP. The elevation of IOP was
significant until four to six hours after dilation. After-
wards, IOP decreased slowly until it reached pre-dilation
level. Further related studies in glaucoma patients are
warranted to characterize the mechanism of increased
IOP after dilation in a diseased state.
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